Open Book Extracts (OBX) entered into a R&D and commercialization partnership with Nalu Bio. The partnership with OBX will allow Nalu Bio to advance its THCV production method from research and ...

Managing a healthy appetite and stable blood-sugar levels don’t typically link with cannabis use, but scientists and industry leaders are weighing in on THCV, a rare cannabinoid that behaves as a ...

You've probably heard of THC and CBD, but there's another active ingredient in hemp and cannabis that's becoming extremely popular: THCV. Often referred to as "diet weed" or the "race car of ...

The most common cannabinoids are THC and CBD, but there are more than 100. Researchers are starting to study lesser-known cannabinoids like CBN, CBG, and THCV. Others are creating lab-grown ...

Cannabis, sometimes referred to as marijuana, is a plant comprised of many different chemicals, including THC, which is responsible for its intoxicating effects. Another well-known cannabis chemical ...

The holidays are fun and full of family, activities, and food. But does marijuana have a natural secret weapon to help you at least not gain weight this season? The holidays are here – turkeys, pie, ...

Rare Cannabinoid Company has announced permanent price reductions on 12 of its rare cannabinoid oils, edibles, and topical products, lowering select items by as much as $20 in an effort to make ...

Munchies are one of the major results of getting really high, so one must be mindful not to over-munch. However, there is a certain part of the cannabis plant that acts as an appetite suppressant.

Scientists have discovered more than 100 cannabinoids in the cannabis plant to date. While the functions of some of these cannabinoids have been identified, others are still being researched. Here are ...

Cronos Group Inc. CRON CRON and Ginkgo Bioworks DNA achieved the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo's platform for organism ...

Radicle Science launches several blinded placebo-controlled clinical trials on rare cannabinoids with 10,000 participants in the first half of 2022 on the heels of completing 25 large-scale CBD ...